Kevin McClintock

4.3k total citations · 1 hit paper
16 papers, 2.2k citations indexed

About

Kevin McClintock is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Kevin McClintock has authored 16 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Kevin McClintock's work include RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Immunotherapy and Immune Responses (4 papers). Kevin McClintock is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Immunotherapy and Immune Responses (4 papers). Kevin McClintock collaborates with scholars based in United States, Switzerland and Germany. Kevin McClintock's co-authors include Adam D. Judge, Ian MacLachlan, Vandana Sood, Dianne Fang, Marjorie Robbins, Janet R. Phelps, Ellen Ambegia, Lorne Palmer, Lina Hu and Iran Tavakoli and has published in prestigious journals such as Advanced Materials, Journal of Clinical Investigation and ACS Nano.

In The Last Decade

Kevin McClintock

16 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

2005 957 citations Adam D. Judge, Vandana Sood et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Kevin McClintock

Since Specialization

Citations

This map shows the geographic impact of Kevin McClintock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin McClintock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin McClintock more than expected).

Fields of papers citing papers by Kevin McClintock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin McClintock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin McClintock. The network helps show where Kevin McClintock may publish in the future.

Co-authorship network of co-authors of Kevin McClintock

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin McClintock. A scholar is included among the top collaborators of Kevin McClintock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin McClintock. Kevin McClintock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic 2024 ·ACS Infectious Diseases ·Emily P. Thi, Xin Ye, Nicholas M. Snead, Amy C. H. Lee, Holly M. Micolochick Steuer, (unknown), (unknown), Christine Espiritu, Andrea Cuconati, (unknown), (unknown), (unknown), Bhavna Paratala, Kevin McClintock, Troy O. Harasym, René Rijnbrand, Angela M. Lam, Michael J. Sofia	6
2	Silicon Ether Ionizable Lipids Enable Potent mRNA Lipid Nanoparticles with Rapid Tissue Clearance 2024 ·ACS Nano ·(unknown), Kieu Lam, Sunny C.Y. Jeng, Kevin McClintock, Lorne Palmer, (unknown), (unknown), Wenchen Zhao, James Heyes	11
3	Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid‐Nanoparticle Components for Therapeutic and Vaccine Applications 2023 ·Advanced Materials ·Kieu Lam, Ada W. S. Leung, (unknown), Mark A. Wood, (unknown), Lorne Palmer, (unknown), (unknown), Kevin McClintock, James Heyes	67
4	ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model 2023 ·Biomedicines ·(unknown), Azita J. Mahiny, (unknown), Kevin McClintock, (unknown), Gábor Boros, Gábor Szabó, Jonas Reinholz, (unknown), Steve Reid, Kieu Lam, (unknown), Melanie Adler, (unknown), James Heyes, Katalin Karikó, (unknown), Irena Vlatkovic	6
5	Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection 2022 ·Molecular Therapy ·Xin Ye, (unknown), (unknown), (unknown), Lorne Palmer, Eleni Samaridou, Kevin McClintock, Viktoriya Borisevich, Thomas W. Geisbert, Robert W. Cross, James Heyes	13
6	Ligand conjugate SAR and enhanced delivery in NHP 2021 ·Molecular Therapy ·(unknown), Kieu Lam, Xin Ye, A. D. Martin, (unknown), Lorne Palmer, David Fraser, Kevin McClintock, (unknown), (unknown), Amy C. H. Lee, Emily P. Thi, Adam D. Judge, James Heyes	8
7	In Vitro and in Vivo Antiviral Activities of AB-423 a Potent Small Molecule Inhibitor of Hepatitis B Virus Capsid Assembly 2016 ·Journal of Hepatology ·Nagraj Mani, Andrew G. Cole, Janet R. Phelps, (unknown), (unknown), Andrea Cuconati, Bruce D. Dorsey, (unknown), Troy O. Harasym, (unknown), (unknown), Hongyang Liang, (unknown), Kevin McClintock, (unknown), Steven Reid, René Rijnbrand, (unknown), (unknown), (unknown)	1
8	Abstract 2829: Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase 1 2011 ·Cancer Research ·Sean C. Semple, Adam D. Judge, Marjorie Robbins, Sandra K. Klimuk, (unknown), Erin Crosley, Ada W.Y. Leung, (unknown), Ellen Ambegia, Kevin McClintock, Ian MacLachlan	17
9	Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice 2009 ·Journal of Clinical Investigation ·Adam D. Judge, Marjorie Robbins, Iran Tavakoli, Jasna Levi, Lina Hu, (unknown), Ellen Ambegia, Kevin McClintock, Ian MacLachlan	273
10	Abstract B204: Development of ALN-VSP: An RNAi therapeutic for liver malignancies 2009 ·Molecular Cancer Therapeutics ·Iva Toudjarska, Adam D. Judge, (unknown), Kevin McClintock, Susan de Jong, Ellen Ambegia, (unknown), Akin Akinc, Timothy Racie, Lloyd B. Jeffs, (unknown), Ian MacLachlan, Dinah W.Y. Sah, Jared Gollob, David Bumcrot	2
11	Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation 2008 ·Human Gene Therapy ·Marjorie Robbins, Adam D. Judge, Ellen Ambegia, (unknown), (unknown), Lorne Palmer, Kevin McClintock, Ian MacLachlan	172
12	Misinterpreting the therapeutic effects of siRNA caused by immune stimulation 2008 ·Human Gene Therapy ·Marjorie Robbins, Adam D. Judge, Ellen Ambegia, (unknown), (unknown), Lorne Palmer, Kevin McClintock, Ian MacLachlan	33
13	2′-O-methyl-modified RNAs Act as TLR7 Antagonists 2007 ·Molecular Therapy ·Marjorie Robbins, Adam D. Judge, (unknown), Kevin McClintock, (unknown), Ian MacLachlan	257
14	Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference 2006 ·The Journal of Infectious Diseases ·Thomas W. Geisbert, Lisa E. Hensley, Elliott Kagan, Erik Z. Yu, Joan B. Geisbert, Kathleen M. Daddario-DiCaprio, Elizabeth A. Fritz, Peter B. Jahrling, Kevin McClintock, Janet R. Phelps, Amy C. H. Lee, Adam D. Judge, Lloyd B. Jeffs, Ian MacLachlan	181
15	Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes 2005 ·Molecular Therapy ·Adam D. Judge, Kevin McClintock, Janet R. Phelps, Ian MacLachlan	225
16	Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA breakdown → 2005 ·Nature Biotechnology ·Adam D. Judge, Vandana Sood, (unknown), Dianne Fang, Kevin McClintock, Ian MacLachlan	957

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact